Reports

Industry Research Reports

Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Medical Care

Published Date: 2026-07-18

Pages: 149 Pages

Report ld: 6271022

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Adeno-Associated Virus (AAV) Packaging Service Market Size(US$)

den_QYR1
cagr

CAGR 2026-2032

11.1%

marketSize

Market Size,2032

USD 2,627

Million

Market Snapshot

Market Size in 2026 (Value)
US$ 1,397 million
Market Forecast in 2032(Value)
US$ 2,627 million
CAGR
11.1%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Adeno-Associated Virus (AAV) Packaging Service market size was US$ 1249 million in 2025 and is forecast to reach a readjusted size of US$ 2627 million by 2032 with a CAGR of 11.1% during the forecast period 2026-2032.

Adeno-associated virus (AAV) packaging services refer to customized development and manufacturing activities in which a customer-provided or jointly designed ITR-containing construct is packaged into a recombinant AAV vector carrying a gene of interest, gene-silencing sequence, gene-editing component or reporter gene. The service workflow generally includes vector design and construction, plasmid preparation, cell culture and transfection, vector harvest, purification, concentration, aliquoting and quality testing, covering research-grade, preclinical-grade and GMP-grade projects. Key upstream inputs include transfer plasmids, Rep/Cap plasmids, helper plasmids, HEK293 or Sf9 cells, culture media, transfection reagents, nucleases, chromatography resins, filtration consumables and analytical reagents. Major downstream customers include universities, research institutes, hospital research platforms, gene therapy developers, biotechnology companies, pharmaceutical companies and CROs, with applications spanning basic research, animal studies, preclinical evaluation, IND submissions, clinical development and commercial manufacturing. The industry's overall gross margin is generally estimated at approximately 32%-48%.

The global market consists of research-grade packaging providers, specialized AAV CROs, integrated cell and gene therapy CDMOs and large biopharmaceutical service groups operating dedicated AAV platforms. Research-grade projects are numerous, relatively short and fragmented, with competition centered on serotype coverage, titer, purity, turnaround time and price. Preclinical and GMP programs are less frequent but require considerably greater investment in process scale-up, analytical methods, batch consistency, quality systems and regulatory documentation. Providers capable of maintaining process continuity from vector design and small-scale packaging through GMP and commercial manufacturing generally develop stronger customer retention, particularly after a program enters clinical development.

Demand is supported by gene-function research, rare-disease and neurological gene therapy, engineered-capsid screening, gene-editing delivery and greater outsourcing by biotechnology companies. Different AAV capsids enable gene delivery to the eye, liver, central nervous system, muscle and other tissues, while dual- and multi-vector systems extend the technology to larger or more complex payloads. The FDA's 2026 approval of the first dual-AAV gene therapy for inherited hearing loss demonstrates the continued expansion of AAV into new vector configurations and therapeutic areas, supporting demand for dual-vector development, analytics and scalable manufacturing.

Adherent HEK293 triple-plasmid transfection remains widely used for research and smaller programs, while suspension HEK293 systems have become the principal route for clinical and commercial scale-up. Baculovirus-Sf9 systems are used in selected large-scale processes. Stable producer-cell lines, dual-plasmid systems and plasmid-reduced technologies are being developed to lower raw-material costs and improve consistency. Downstream competition is moving beyond vector-genome titer toward full-capsid enrichment, genome-integrity control and tighter reduction of host-cell proteins, residual DNA, residual plasmids and replication-competent AAV.

The principal constraints include gene therapy financing and pipeline reprioritization, high clinical attrition, underutilized GMP facilities, elevated manufacturing costs and the immunological and safety limitations of AAV. Serious liver-related safety events led the FDA to restrict the use of a major AAV gene therapy in 2025, increasing the focus on dose selection, impurity control, clinical monitoring and long-term follow-up. At the same time, the FDA introduced a more flexible approach to certain cell and gene therapy CMC requirements in 2026, which may help selected rare-disease programs progress more efficiently but does not reduce expectations for identity, potency, purity and manufacturing consistency.

The global Adeno-Associated Virus (AAV) Packaging Service market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.

MARKET SEGMENTATION

By Company

  • Thermo Fisher Scientific
  • Lonza
  • Charles River Laboratories
  • Catalent
  • AGC Biologics
  • SK pharmteco
  • OXB
  • Forge Biologics
  • Viralgen
  • Andelyn Biosciences
  • Revvity
  • Virovek
  • Fortis Life Sciences
  • SignaGen Laboratories
  • Applied Biological Materials
  • Takara Bio
  • VectorBuilder
  • GenScript ProBio
  • PackGene Biotech
  • OBiO Technology
  • Porton Advanced
  • HanBio

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Research Grade
  • Preclinical Grade
  • GMP Grade

Segment by Application

  • Academic and Research Institutions
  • Biotechnology Companies
  • Other

Segment by Category

  • Packaging Only
  • Vector Construction and Packaging
  • End-to-End Development and Manufacturing

Segment by Division

  • Adherent HEK293
  • Suspension HEK293
  • Baculovirus-Sf9
  • Other

Why This Report?

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Adeno-Associated Virus (AAV) Packaging Service value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032

1.2.2 Research Grade

1.2.3 Preclinical Grade

1.2.4 GMP Grade

1.3 Market by Application

1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032

1.3.2 Academic and Research Institutions

1.3.3 Biotechnology Companies

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Global Growth Trends

2.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Perspective (2021-2032)

2.2 Global Market Size by Region: 2021 vs 2025 vs 2032

2.3 Global Adeno-Associated Virus (AAV) Packaging Service Market Share by Revenue, by Region (2021-2026)

2.4 Global Adeno-Associated Virus (AAV) Packaging Service Revenue Forecast by Region (2027-2032)

2.5 Major Regions and Emerging Markets Analysis

2.5.1 North America Adeno-Associated Virus (AAV) Packaging Service Market Size and Prospective (2021-2032)

2.5.2 Europe Adeno-Associated Virus (AAV) Packaging Service Market Size and Prospective (2021-2032)

2.5.3 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Size and Prospective (2021-2032)

2.5.4 Latin America Adeno-Associated Virus (AAV) Packaging Service Market Size and Prospective (2021-2032)

2.5.5 Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Size and Prospective (2021-2032)

muLu

3 Breakdown Data by Type

3.1 Global Adeno-Associated Virus (AAV) Packaging Service Historical Market Size by Type (2021-2026)

3.2 Global Adeno-Associated Virus (AAV) Packaging Service Forecasted Market Size by Type (2027-2032)

3.3 Representative Players for Different Types of Adeno-Associated Virus (AAV) Packaging Service

muLu

4 Breakdown Data by Application

4.1 Global Adeno-Associated Virus (AAV) Packaging Service Historical Market Size by Application (2021-2026)

4.2 Global Adeno-Associated Virus (AAV) Packaging Service Forecasted Market Size by Application (2027-2032)

4.3 New Sources of Growth in Adeno-Associated Virus (AAV) Packaging Service Applications

muLu

5 Competitive Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Adeno-Associated Virus (AAV) Packaging Service Players by Revenue (2021-2026)

5.1.2 Global Adeno-Associated Virus (AAV) Packaging Service Market Share by Revenue, by Players (2021-2026)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Adeno-Associated Virus (AAV) Packaging Service Revenue

5.4 Global Adeno-Associated Virus (AAV) Packaging Service Market Concentration Analysis

5.4.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Adeno-Associated Virus (AAV) Packaging Service Revenue in 2025

5.5 Global Key Players of Adeno-Associated Virus (AAV) Packaging Service Head Offices and Areas Served

5.6 Global Key Players of Adeno-Associated Virus (AAV) Packaging Service, Product and Application

5.7 Global Key Players of Adeno-Associated Virus (AAV) Packaging Service, Date of Entry into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

muLu

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Adeno-Associated Virus (AAV) Packaging Service Revenue by Company (2021-2026)

6.1.2 North America Market Size by Type

6.1.2.1 North America Adeno-Associated Virus (AAV) Packaging Service Market Size by Type (2021-2026)

6.1.2.2 North America Adeno-Associated Virus (AAV) Packaging Service Market Share by Type (2021-2026)

6.1.3 North America Market Size by Application

6.1.3.1 North America Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (2021-2026)

6.1.3.2 North America Adeno-Associated Virus (AAV) Packaging Service Market Share by Application (2021-2026)

6.1.4 North America Adeno-Associated Virus (AAV) Packaging Service Major Customers

6.1.5 North America Market Trends and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Adeno-Associated Virus (AAV) Packaging Service Revenue by Company (2021-2026)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Adeno-Associated Virus (AAV) Packaging Service Market Size by Type (2021-2026)

6.2.2.2 Europe Adeno-Associated Virus (AAV) Packaging Service Market Share by Type (2021-2026)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (2021-2026)

6.2.3.2 Europe Adeno-Associated Virus (AAV) Packaging Service Market Share by Application (2021-2026)

6.2.4 Europe Adeno-Associated Virus (AAV) Packaging Service Major Customers

6.2.5 Europe Market Trends and Opportunities

6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers

6.3.1 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Revenue by Company (2021-2026)

6.3.2 Asia-Pacific Market Size by Type

6.3.2.1 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Size by Type (2021-2026)

6.3.2.2 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Share by Type (2021-2026)

6.3.3 Asia-Pacific Market Size by Application

6.3.3.1 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (2021-2026)

6.3.3.2 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Share by Application (2021-2026)

6.3.4 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Major Customers

6.3.5 Asia-Pacific Market Trends and Opportunities

6.4 Latin America Market: Players, Segments, Downstream and Major Customers

6.4.1 Latin America Adeno-Associated Virus (AAV) Packaging Service Revenue by Company (2021-2026)

6.4.2 Latin America Market Size by Type

6.4.2.1 Latin America Adeno-Associated Virus (AAV) Packaging Service Market Size by Type (2021-2026)

6.4.2.2 Latin America Adeno-Associated Virus (AAV) Packaging Service Market Share by Type (2021-2026)

6.4.3 Latin America Market Size by Application

6.4.3.1 Latin America Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (2021-2026)

6.4.3.2 Latin America Adeno-Associated Virus (AAV) Packaging Service Market Share by Application (2021-2026)

6.4.4 Latin America Adeno-Associated Virus (AAV) Packaging Service Major Customers

6.4.5 Latin America Market Trends and Opportunities

6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers

6.5.1 Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Revenue by Company (2021-2026)

6.5.2 Middle East & Africa Market Size by Type

6.5.2.1 Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Size by Type (2021-2026)

6.5.2.2 Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Share by Type (2021-2026)

6.5.3 Middle East & Africa Market Size by Application

6.5.3.1 Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (2021-2026)

6.5.3.2 Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Share by Application (2021-2026)

6.5.4 Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Major Customers

6.5.5 Middle East & Africa Market Trends and Opportunities

muLu

7 Key Player Profiles

7.1 Thermo Fisher Scientific

7.1.1 Thermo Fisher Scientific Company Details

7.1.2 Thermo Fisher Scientific Business Overview

7.1.3 Thermo Fisher Scientific Adeno-Associated Virus (AAV) Packaging Service Introduction

7.1.4 Thermo Fisher Scientific Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.1.5 Thermo Fisher Scientific Recent Development

7.2 Lonza

7.2.1 Lonza Company Details

7.2.2 Lonza Business Overview

7.2.3 Lonza Adeno-Associated Virus (AAV) Packaging Service Introduction

7.2.4 Lonza Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.2.5 Lonza Recent Development

7.3 Charles River Laboratories

7.3.1 Charles River Laboratories Company Details

7.3.2 Charles River Laboratories Business Overview

7.3.3 Charles River Laboratories Adeno-Associated Virus (AAV) Packaging Service Introduction

7.3.4 Charles River Laboratories Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.3.5 Charles River Laboratories Recent Development

7.4 Catalent

7.4.1 Catalent Company Details

7.4.2 Catalent Business Overview

7.4.3 Catalent Adeno-Associated Virus (AAV) Packaging Service Introduction

7.4.4 Catalent Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.4.5 Catalent Recent Development

7.5 AGC Biologics

7.5.1 AGC Biologics Company Details

7.5.2 AGC Biologics Business Overview

7.5.3 AGC Biologics Adeno-Associated Virus (AAV) Packaging Service Introduction

7.5.4 AGC Biologics Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.5.5 AGC Biologics Recent Development

7.6 SK pharmteco

7.6.1 SK pharmteco Company Details

7.6.2 SK pharmteco Business Overview

7.6.3 SK pharmteco Adeno-Associated Virus (AAV) Packaging Service Introduction

7.6.4 SK pharmteco Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.6.5 SK pharmteco Recent Development

7.7 OXB

7.7.1 OXB Company Details

7.7.2 OXB Business Overview

7.7.3 OXB Adeno-Associated Virus (AAV) Packaging Service Introduction

7.7.4 OXB Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.7.5 OXB Recent Development

7.8 Forge Biologics

7.8.1 Forge Biologics Company Details

7.8.2 Forge Biologics Business Overview

7.8.3 Forge Biologics Adeno-Associated Virus (AAV) Packaging Service Introduction

7.8.4 Forge Biologics Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.8.5 Forge Biologics Recent Development

7.9 Viralgen

7.9.1 Viralgen Company Details

7.9.2 Viralgen Business Overview

7.9.3 Viralgen Adeno-Associated Virus (AAV) Packaging Service Introduction

7.9.4 Viralgen Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.9.5 Viralgen Recent Development

7.10 Andelyn Biosciences

7.10.1 Andelyn Biosciences Company Details

7.10.2 Andelyn Biosciences Business Overview

7.10.3 Andelyn Biosciences Adeno-Associated Virus (AAV) Packaging Service Introduction

7.10.4 Andelyn Biosciences Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.10.5 Andelyn Biosciences Recent Development

7.11 Revvity

7.11.1 Revvity Company Details

7.11.2 Revvity Business Overview

7.11.3 Revvity Adeno-Associated Virus (AAV) Packaging Service Introduction

7.11.4 Revvity Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.11.5 Revvity Recent Development

7.12 Virovek

7.12.1 Virovek Company Details

7.12.2 Virovek Business Overview

7.12.3 Virovek Adeno-Associated Virus (AAV) Packaging Service Introduction

7.12.4 Virovek Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.12.5 Virovek Recent Development

7.13 Fortis Life Sciences

7.13.1 Fortis Life Sciences Company Details

7.13.2 Fortis Life Sciences Business Overview

7.13.3 Fortis Life Sciences Adeno-Associated Virus (AAV) Packaging Service Introduction

7.13.4 Fortis Life Sciences Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.13.5 Fortis Life Sciences Recent Development

7.14 SignaGen Laboratories

7.14.1 SignaGen Laboratories Company Details

7.14.2 SignaGen Laboratories Business Overview

7.14.3 SignaGen Laboratories Adeno-Associated Virus (AAV) Packaging Service Introduction

7.14.4 SignaGen Laboratories Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.14.5 SignaGen Laboratories Recent Development

7.15 Applied Biological Materials

7.15.1 Applied Biological Materials Company Details

7.15.2 Applied Biological Materials Business Overview

7.15.3 Applied Biological Materials Adeno-Associated Virus (AAV) Packaging Service Introduction

7.15.4 Applied Biological Materials Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.15.5 Applied Biological Materials Recent Development

7.16 Takara Bio

7.16.1 Takara Bio Company Details

7.16.2 Takara Bio Business Overview

7.16.3 Takara Bio Adeno-Associated Virus (AAV) Packaging Service Introduction

7.16.4 Takara Bio Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.16.5 Takara Bio Recent Development

7.17 VectorBuilder

7.17.1 VectorBuilder Company Details

7.17.2 VectorBuilder Business Overview

7.17.3 VectorBuilder Adeno-Associated Virus (AAV) Packaging Service Introduction

7.17.4 VectorBuilder Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.17.5 VectorBuilder Recent Development

7.18 GenScript ProBio

7.18.1 GenScript ProBio Company Details

7.18.2 GenScript ProBio Business Overview

7.18.3 GenScript ProBio Adeno-Associated Virus (AAV) Packaging Service Introduction

7.18.4 GenScript ProBio Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.18.5 GenScript ProBio Recent Development

7.19 PackGene Biotech

7.19.1 PackGene Biotech Company Details

7.19.2 PackGene Biotech Business Overview

7.19.3 PackGene Biotech Adeno-Associated Virus (AAV) Packaging Service Introduction

7.19.4 PackGene Biotech Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.19.5 PackGene Biotech Recent Development

7.20 OBiO Technology

7.20.1 OBiO Technology Company Details

7.20.2 OBiO Technology Business Overview

7.20.3 OBiO Technology Adeno-Associated Virus (AAV) Packaging Service Introduction

7.20.4 OBiO Technology Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.20.5 OBiO Technology Recent Development

7.21 Porton Advanced

7.21.1 Porton Advanced Company Details

7.21.2 Porton Advanced Business Overview

7.21.3 Porton Advanced Adeno-Associated Virus (AAV) Packaging Service Introduction

7.21.4 Porton Advanced Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.21.5 Porton Advanced Recent Development

7.22 HanBio

7.22.1 HanBio Company Details

7.22.2 HanBio Business Overview

7.22.3 HanBio Adeno-Associated Virus (AAV) Packaging Service Introduction

7.22.4 HanBio Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)

7.22.5 HanBio Recent Development

muLu

8 Adeno-Associated Virus (AAV) Packaging Service Market Dynamics

8.1 Adeno-Associated Virus (AAV) Packaging Service Industry Trends

8.2 Adeno-Associated Virus (AAV) Packaging Service Market Drivers

8.3 Adeno-Associated Virus (AAV) Packaging Service Market Challenges

8.4 Adeno-Associated Virus (AAV) Packaging Service Market Restraints

muLu

9 Research Findings and Conclusion

muLu

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Adeno-Associated Virus (AAV) Packaging Service Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Adeno-Associated Virus (AAV) Packaging Service Revenue Share by Region (2021-2026)
Table 6. Global Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Adeno-Associated Virus (AAV) Packaging Service Revenue Share Forecast by Region (2027-2032)
Table 8. Global Adeno-Associated Virus (AAV) Packaging Service Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Adeno-Associated Virus (AAV) Packaging Service Market Share by Revenue, by Type (2021-2026)
Table 10. Global Adeno-Associated Virus (AAV) Packaging Service Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Adeno-Associated Virus (AAV) Packaging Service Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Adeno-Associated Virus (AAV) Packaging Service Market Share by Revenue, by Application (2021-2026)
Table 15. Global Adeno-Associated Virus (AAV) Packaging Service Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Adeno-Associated Virus (AAV) Packaging Service Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Adeno-Associated Virus (AAV) Packaging Service Applications
Table 18. Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Adeno-Associated Virus (AAV) Packaging Service Market Share by Players (2021-2026)
Table 20. Global Top Adeno-Associated Virus (AAV) Packaging Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adeno-Associated Virus (AAV) Packaging Service as of 2025)
Table 21. Ranking of Global Top Adeno-Associated Virus (AAV) Packaging Service Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Adeno-Associated Virus (AAV) Packaging Service Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Adeno-Associated Virus (AAV) Packaging Service, Headquarters and Area Served
Table 24. Global Key Players of Adeno-Associated Virus (AAV) Packaging Service, Product and Application
Table 25. Global Key Players of Adeno-Associated Virus (AAV) Packaging Service, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Adeno-Associated Virus (AAV) Packaging Service Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Adeno-Associated Virus (AAV) Packaging Service Market Share by Revenue, by Company (2021-2026)
Table 29. North America Adeno-Associated Virus (AAV) Packaging Service Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Adeno-Associated Virus (AAV) Packaging Service Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Adeno-Associated Virus (AAV) Packaging Service Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Adeno-Associated Virus (AAV) Packaging Service Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America Adeno-Associated Virus (AAV) Packaging Service Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America Adeno-Associated Virus (AAV) Packaging Service Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America Adeno-Associated Virus (AAV) Packaging Service Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (2021-2026) & (US$ Million)
Table 47. Thermo Fisher Scientific Company Details
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific Adeno-Associated Virus (AAV) Packaging Service Product
Table 50. Thermo Fisher Scientific Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 51. Thermo Fisher Scientific Recent Development
Table 52. Lonza Company Details
Table 53. Lonza Business Overview
Table 54. Lonza Adeno-Associated Virus (AAV) Packaging Service Product
Table 55. Lonza Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 56. Lonza Recent Development
Table 57. Charles River Laboratories Company Details
Table 58. Charles River Laboratories Business Overview
Table 59. Charles River Laboratories Adeno-Associated Virus (AAV) Packaging Service Product
Table 60. Charles River Laboratories Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 61. Charles River Laboratories Recent Development
Table 62. Catalent Company Details
Table 63. Catalent Business Overview
Table 64. Catalent Adeno-Associated Virus (AAV) Packaging Service Product
Table 65. Catalent Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 66. Catalent Recent Development
Table 67. AGC Biologics Company Details
Table 68. AGC Biologics Business Overview
Table 69. AGC Biologics Adeno-Associated Virus (AAV) Packaging Service Product
Table 70. AGC Biologics Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 71. AGC Biologics Recent Development
Table 72. SK pharmteco Company Details
Table 73. SK pharmteco Business Overview
Table 74. SK pharmteco Adeno-Associated Virus (AAV) Packaging Service Product
Table 75. SK pharmteco Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 76. SK pharmteco Recent Development
Table 77. OXB Company Details
Table 78. OXB Business Overview
Table 79. OXB Adeno-Associated Virus (AAV) Packaging Service Product
Table 80. OXB Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 81. OXB Recent Development
Table 82. Forge Biologics Company Details
Table 83. Forge Biologics Business Overview
Table 84. Forge Biologics Adeno-Associated Virus (AAV) Packaging Service Product
Table 85. Forge Biologics Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 86. Forge Biologics Recent Development
Table 87. Viralgen Company Details
Table 88. Viralgen Business Overview
Table 89. Viralgen Adeno-Associated Virus (AAV) Packaging Service Product
Table 90. Viralgen Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 91. Viralgen Recent Development
Table 92. Andelyn Biosciences Company Details
Table 93. Andelyn Biosciences Business Overview
Table 94. Andelyn Biosciences Adeno-Associated Virus (AAV) Packaging Service Product
Table 95. Andelyn Biosciences Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 96. Andelyn Biosciences Recent Development
Table 97. Revvity Company Details
Table 98. Revvity Business Overview
Table 99. Revvity Adeno-Associated Virus (AAV) Packaging Service Product
Table 100. Revvity Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 101. Revvity Recent Development
Table 102. Virovek Company Details
Table 103. Virovek Business Overview
Table 104. Virovek Adeno-Associated Virus (AAV) Packaging Service Product
Table 105. Virovek Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 106. Virovek Recent Development
Table 107. Fortis Life Sciences Company Details
Table 108. Fortis Life Sciences Business Overview
Table 109. Fortis Life Sciences Adeno-Associated Virus (AAV) Packaging Service Product
Table 110. Fortis Life Sciences Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 111. Fortis Life Sciences Recent Development
Table 112. SignaGen Laboratories Company Details
Table 113. SignaGen Laboratories Business Overview
Table 114. SignaGen Laboratories Adeno-Associated Virus (AAV) Packaging Service Product
Table 115. SignaGen Laboratories Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 116. SignaGen Laboratories Recent Development
Table 117. Applied Biological Materials Company Details
Table 118. Applied Biological Materials Business Overview
Table 119. Applied Biological Materials Adeno-Associated Virus (AAV) Packaging Service Product
Table 120. Applied Biological Materials Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 121. Applied Biological Materials Recent Development
Table 122. Takara Bio Company Details
Table 123. Takara Bio Business Overview
Table 124. Takara Bio Adeno-Associated Virus (AAV) Packaging Service Product
Table 125. Takara Bio Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 126. Takara Bio Recent Development
Table 127. VectorBuilder Company Details
Table 128. VectorBuilder Business Overview
Table 129. VectorBuilder Adeno-Associated Virus (AAV) Packaging Service Product
Table 130. VectorBuilder Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 131. VectorBuilder Recent Development
Table 132. GenScript ProBio Company Details
Table 133. GenScript ProBio Business Overview
Table 134. GenScript ProBio Adeno-Associated Virus (AAV) Packaging Service Product
Table 135. GenScript ProBio Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 136. GenScript ProBio Recent Development
Table 137. PackGene Biotech Company Details
Table 138. PackGene Biotech Business Overview
Table 139. PackGene Biotech Adeno-Associated Virus (AAV) Packaging Service Product
Table 140. PackGene Biotech Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 141. PackGene Biotech Recent Development
Table 142. OBiO Technology Company Details
Table 143. OBiO Technology Business Overview
Table 144. OBiO Technology Adeno-Associated Virus (AAV) Packaging Service Product
Table 145. OBiO Technology Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 146. OBiO Technology Recent Development
Table 147. Porton Advanced Company Details
Table 148. Porton Advanced Business Overview
Table 149. Porton Advanced Adeno-Associated Virus (AAV) Packaging Service Product
Table 150. Porton Advanced Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 151. Porton Advanced Recent Development
Table 152. HanBio Company Details
Table 153. HanBio Business Overview
Table 154. HanBio Adeno-Associated Virus (AAV) Packaging Service Product
Table 155. HanBio Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026) & (US$ Million)
Table 156. HanBio Recent Development
Table 157. Adeno-Associated Virus (AAV) Packaging Service Market Trends
Table 158. Adeno-Associated Virus (AAV) Packaging Service Market Drivers
Table 159. Adeno-Associated Virus (AAV) Packaging Service Market Challenges
Table 160. Adeno-Associated Virus (AAV) Packaging Service Market Restraints
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Adeno-Associated Virus (AAV) Packaging Service Product Picture
Figure 2. Global Adeno-Associated Virus (AAV) Packaging Service Market Share by Type: 2025 vs 2032
Figure 3. Research Grade Features
Figure 4. Preclinical Grade Features
Figure 5. GMP Grade Features
Figure 6. Global Adeno-Associated Virus (AAV) Packaging Service Market Share by Application: 2025 vs 2032
Figure 7. Academic and Research Institutions
Figure 8. Biotechnology Companies
Figure 9. Other
Figure 10. Adeno-Associated Virus (AAV) Packaging Service Report Years Considered
Figure 11. Global Adeno-Associated Virus (AAV) Packaging Service Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 12. Global Adeno-Associated Virus (AAV) Packaging Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Adeno-Associated Virus (AAV) Packaging Service Market Share by Revenue, by Region: 2021 vs 2025
Figure 14. North America Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) Growth Rate (2021-2032)
Figure 15. Europe Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Latin America Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Global Adeno-Associated Virus (AAV) Packaging Service Market Share by Players in 2025
Figure 20. Global Top Adeno-Associated Virus (AAV) Packaging Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adeno-Associated Virus (AAV) Packaging Service as of 2025)
Figure 21. The Top 10 and 5 Players Market Share by Adeno-Associated Virus (AAV) Packaging Service Revenue in 2025
Figure 22. North America Adeno-Associated Virus (AAV) Packaging Service Market Share by Type (2021-2026)
Figure 23. North America Adeno-Associated Virus (AAV) Packaging Service Market Share by Application (2021-2026)
Figure 24. Europe Adeno-Associated Virus (AAV) Packaging Service Market Share by Type (2021-2026)
Figure 25. Europe Adeno-Associated Virus (AAV) Packaging Service Market Share by Application (2021-2026)
Figure 26. Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Share by Type (2021-2026)
Figure 27. Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Share by Application (2021-2026)
Figure 28. Latin America Adeno-Associated Virus (AAV) Packaging Service Market Share by Type (2021-2026)
Figure 29. Latin America Adeno-Associated Virus (AAV) Packaging Service Market Share by Application (2021-2026)
Figure 30. Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Share by Type (2021-2026)
Figure 31. Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Share by Application (2021-2026)
Figure 32. Thermo Fisher Scientific Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 33. Lonza Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 34. Charles River Laboratories Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 35. Catalent Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 36. AGC Biologics Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 37. SK pharmteco Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 38. OXB Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 39. Forge Biologics Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 40. Viralgen Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 41. Andelyn Biosciences Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 42. Revvity Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 43. Virovek Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 44. Fortis Life Sciences Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 45. SignaGen Laboratories Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 46. Applied Biological Materials Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 47. Takara Bio Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 48. VectorBuilder Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 49. GenScript ProBio Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 50. PackGene Biotech Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 51. OBiO Technology Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 52. Porton Advanced Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 53. HanBio Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021-2026)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Adeno-Associated Virus (AAV) Packaging Service in 2032?zhanKai
The global market size of Adeno-Associated Virus (AAV) Packaging Service in 2032 was 2627 Million USD.
What was the global market size of Adeno-Associated Virus (AAV) Packaging Service in 2026?shouQi
What is the annual compound growth rate of the global Adeno-Associated Virus (AAV) Packaging Service market size from 2026 to 2032?shouQi
Which region is expected to have the highest market share?shouQi
Which companies rank high in the global Adeno-Associated Virus (AAV) Packaging Service market?shouQi
den_biaoTiZhungShi

Related Reports

Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Medical Care

Published Date: 2026-07-18

Pages: 149 Pages

Report ld: 6271022

CHOOSE LICENSE TYPE
tip

USD 4250.00

tip

USD 6375.00

tip

USD 8500.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Online

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

MARKET SEGMENTATION

den_ic7

Why This Report?

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now